Profitability
by Company within Biotechnology & Drugs Industry
|
| Company |
Quarter |
Gross Margin |
Net Margin |
Cash flow Margin |
ROE |
| Abbvie Inc |
3 Q |
60.86 % |
17.93 % |
14.52 % |
180.74 % |
| Arca Biopharma Inc |
3 Q |
- |
- |
- |
- |
| American Bio Medica Corp |
3 Q |
26.61 % |
- |
- |
- |
| Acorda Therapeutics inc |
3 Q |
77.08 % |
13.84 % |
33 % |
16.08 % |
| Aclaris Therapeutics Inc |
3 Q |
17.94 % |
- |
- |
- |
| Acasti Pharma Inc |
2 Q |
- |
- |
- |
- |
| Actavis Plc |
4 Q |
27.97 % |
- |
- |
- |
| Ocata Therapeutics, Inc. |
0 Q |
- |
- |
- |
- |
| Adaptimmune Therapeutics Plc |
3 Q |
- |
- |
- |
- |
| Fennec Pharmaceuticals Inc. |
0 Q |
- |
- |
- |
- |
| Adma Biologics Inc |
3 Q |
- |
- |
- |
- |
| Adverum Biotechnologies Inc |
3 Q |
- |
- |
- |
- |
| Aerie Pharmaceuticals Inc |
3 Q |
73.2 % |
- |
- |
- |
| Agenus Inc |
3 Q |
93.86 % |
- |
- |
- |
| Allergan plc |
1 Q |
82.71 % |
10.51 % |
- |
- |
| Applied Genetic Technologies Corp |
3 Q |
- |
- |
- |
- |
| Akers Biosciences Inc |
3 Q |
- |
- |
- |
- |
| Alder Biopharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Alliance Bioenergy Plus, Inc. |
1 Q |
- |
- |
- |
- |
| Allena Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Amarillo Biosciences Inc |
3 Q |
35.94 % |
- |
- |
- |
| Amarantus Bioscience Holdings, Inc. |
0 Q |
- |
- |
- |
- |
| Amarantus Bioscience Holdings, Inc. |
0 Q |
- |
- |
- |
- |
| Amgen Inc |
3 Q |
- |
- |
- |
72.12 % |
| Albany Molecular Research Inc |
2 Q |
23.83 % |
- |
4.07 % |
- |
| Amyris Inc |
3 Q |
24.62 % |
- |
- |
- |
| Alpha Network Alliance Ventures Inc. |
2 Q |
33.16 % |
- |
4.26 % |
- |
| Aeolus Pharmaceuticals, Inc. |
4 Q |
- |
- |
- |
- |
| Apollo Endosurgery inc |
3 Q |
54.47 % |
- |
- |
- |
| Armata Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Cellect Biotechnology Ltd |
4 Q |
- |
- |
- |
113.28 % |
| Aptose Biosciences Inc |
3 Q |
- |
- |
- |
- |
| Aptevo Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Ariad Pharmaceuticals Inc |
0 Q |
- |
- |
- |
- |
| Armo Biosciences, Inc. |
1 Q |
- |
- |
- |
- |
| Arno Therapeutics, Inc |
0 Q |
- |
- |
- |
- |
| Aerpio Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Aslan Pharmaceuticals Ltd |
4 Q |
86.42 % |
- |
- |
- |
| Assembly Biosciences inc |
3 Q |
- |
- |
- |
- |
| Asterias Biotherapeutics, Inc. |
1 Q |
86.82 % |
- |
- |
- |
| Atara Biotherapeutics Inc |
3 Q |
- |
- |
- |
- |
| Kubota Pharmaceutical Holdings Co Ltd |
0 Q |
- |
- |
- |
- |
| Avantor Inc |
2 Q |
33.18 % |
4.07 % |
4.67 % |
4.38 % |
| Anavex Life Sciences Corp |
2 Q |
- |
- |
- |
- |
| Axim Biotechnologies Inc |
2 Q |
- |
- |
- |
- |
| Axcella Health Inc |
3 Q |
- |
- |
- |
- |
| Ayala Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Aytu Bioscience Inc |
3 Q |
71.75 % |
- |
- |
- |
| Azurrx Biopharma Inc |
3 Q |
- |
- |
- |
- |
| Brickell Biotech Inc |
3 Q |
- |
- |
- |
- |
| Brainstorm Cell Therapeutics inc |
3 Q |
- |
- |
- |
- |
| Biocryst Pharmaceuticals Inc |
3 Q |
75.14 % |
- |
- |
- |
| Black Diamond Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Beam Therapeutics Inc |
2 Q |
- |
- |
- |
1.68 % |
| Beesfree, Inc. |
0 Q |
- |
- |
- |
- |
| Biofrontera Ag |
4 Q |
78.91 % |
- |
- |
- |
| Bg Medicine, Inc. |
0 Q |
- |
- |
- |
- |
| U.s. Stem Cell, Inc. |
3 Q |
12.28 % |
- |
- |
- |
| Premier Biomedical Inc |
4 Q |
- |
- |
- |
- |
| Biogen Inc |
3 Q |
86.7 % |
20.85 % |
- |
42.94 % |
| Bionovate Technologies Corp |
3 Q |
- |
- |
- |
- |
| Berkeley Lights Inc |
2 Q |
65.87 % |
- |
- |
- |
| Immucor Inc |
0 Q |
- |
- |
- |
- |
| Bluebird Bio Inc |
3 Q |
93.16 % |
- |
- |
- |
| Mj Biotech, Inc. |
4 Q |
- |
- |
- |
- |
| Bionano Genomics Inc |
3 Q |
33.52 % |
- |
5.33 % |
- |
| Bionovo Inc |
0 Q |
- |
- |
- |
- |
| Audentes Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Bohai Pharmaceuticals Group, Inc. |
4 Q |
76.61 % |
15.54 % |
- |
19.11 % |
| Organicell Regenerative Medicine Inc |
4 Q |
74.19 % |
- |
- |
- |
| Biorestorative Therapies, Inc. |
3 Q |
- |
- |
- |
- |
| Boston Therapeutics Inc |
4 Q |
- |
- |
- |
- |
| Biondvax Pharmaceuticals Ltd |
4 Q |
- |
- |
- |
- |
| Burzynski Research Institute Inc |
3 Q |
- |
- |
- |
- |
| Cabaletta Bio Inc |
3 Q |
- |
- |
- |
- |
| Cadence Pharmaceuticals Inc |
4 Q |
67.3 % |
- |
- |
- |
| Cannis Inc |
2 Q |
- |
- |
- |
- |
| Cannapowder Inc |
4 Q |
- |
- |
- |
- |
| Capricor Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Capstone Therapeutics Corp. |
2 Q |
- |
- |
- |
- |
| Casi Pharmaceuticals Inc |
3 Q |
56.91 % |
- |
- |
- |
| Catalyst Biosciences Inc |
3 Q |
- |
- |
- |
- |
| Cellular Biomedicine Group Inc |
3 Q |
76.41 % |
- |
- |
- |
| China Botanic Pharmaceutical |
0 Q |
- |
- |
- |
- |
| China Biologic Products Holdings Inc |
4 Q |
- |
32.44 % |
- |
9.21 % |
| Cellcyte Genetics Corp. |
0 Q |
- |
- |
- |
- |
| Cidara Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Chromadex Corporation |
3 Q |
59.62 % |
- |
- |
- |
| Cardax Inc |
3 Q |
58.62 % |
- |
- |
- |
| Creative Medical Technology Holdings Inc |
3 Q |
77.14 % |
- |
2.19 % |
- |
| Cen Biotech Inc |
3 Q |
- |
- |
- |
- |
| Cerecor Inc |
3 Q |
93.1 % |
- |
- |
- |
| Compugen Ltd |
4 Q |
- |
- |
- |
- |
| Coherus Biosciences inc |
3 Q |
- |
24.6 % |
59.75 % |
88.44 % |
| Chelsea Therapeutics International, Ltd. |
0 Q |
- |
- |
- |
- |
| China Kangtai Cactus Bio-tech, Inc. |
0 Q |
- |
- |
- |
- |
| Celldex Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Cellectis S a |
4 Q |
25 % |
- |
- |
- |
| Checkmate Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Clementia Pharmaceuticals Inc. |
1 Q |
- |
- |
- |
- |
| Cell Medx Corp |
3 Q |
74.85 % |
- |
- |
- |
| United Cannabis Corp |
3 Q |
- |
- |
- |
- |
| Cannabics Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Compass Biotechnologies Inc. |
0 Q |
- |
- |
- |
- |
| Cohbar Inc |
3 Q |
- |
- |
- |
- |
| Cocrystal Pharma Inc |
3 Q |
- |
- |
- |
- |
| Core Lithium Corp. |
3 Q |
- |
- |
- |
- |
| Cannapharmarx Inc |
3 Q |
- |
- |
- |
- |
| Cardiff Oncology inc |
3 Q |
- |
- |
- |
- |
| Curis Inc |
3 Q |
- |
- |
- |
- |
| Crispr Therapeutics Ag |
3 Q |
- |
- |
- |
- |
| American Cryostem Corp |
2 Q |
96.75 % |
- |
12.54 % |
- |
| Champions Oncology Inc |
2 Q |
44.11 % |
0.79 % |
- |
- |
| Cyclo Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Cytomx Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Citius Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Cue Biopharma Inc |
3 Q |
- |
- |
- |
- |
| Cel sci Corporation |
2 Q |
- |
- |
- |
- |
| Cv Sciences Inc |
3 Q |
44.18 % |
- |
- |
- |
| Cv Sciences, Inc. |
1 Q |
68.91 % |
7.67 % |
- |
- |
| Cyanotech Corp |
3 Q |
38.51 % |
1.81 % |
10.83 % |
3.67 % |
| Cytodyn Inc |
3 Q |
- |
- |
- |
- |
| Cytrx Corp |
3 Q |
- |
- |
- |
- |
| Dbv Technologies S a |
4 Q |
- |
- |
- |
- |
| Enochian Biosciences Inc |
3 Q |
- |
- |
- |
- |
| Diadexus, Inc. |
0 Q |
- |
- |
- |
- |
| Diffusion Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Dimension Therapeutics, Inc. |
3 Q |
- |
- |
- |
- |
| Dna Testing Centers Corp |
4 Q |
- |
- |
- |
- |
| Dendreon Corp |
0 Q |
- |
- |
- |
- |
| Denali Therapeutics Inc |
3 Q |
- |
- |
- |
6.7 % |
| Noho, Inc. |
0 Q |
- |
- |
- |
- |
| Ds Healthcare Group, Inc. |
2 Q |
58.96 % |
- |
- |
- |
| Dyadic International Inc |
3 Q |
35.89 % |
- |
- |
- |
| Emergent Biosolutions Inc |
3 Q |
61.32 % |
10.25 % |
37.95 % |
14.44 % |
| Pds Biotechnology Corp |
3 Q |
- |
- |
- |
- |
| Eidos Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Eiger Biopharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Eloxx Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Empowered Products, Inc. |
0 Q |
- |
- |
- |
- |
| Endonovo Therapeutics Inc |
3 Q |
98.1 % |
- |
- |
- |
| Entremed Inc |
0 Q |
- |
- |
- |
- |
| Entest Group Inc |
4 Q |
- |
- |
- |
- |
| Enumeral Biomedical Holdings, Inc. |
3 Q |
- |
- |
- |
- |
| Enzon Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Enzymotec Ltd. |
0 Q |
- |
- |
- |
- |
| Entia Biosciences, Inc. |
4 Q |
77.99 % |
- |
- |
- |
| Erytech Pharma S a |
4 Q |
- |
- |
- |
- |
| Establishment Labs Holdings Inc |
2 Q |
69.07 % |
- |
- |
- |
| Eastgate Biotech Corp |
2 Q |
50.28 % |
- |
34.44 % |
- |
| 89bio Inc |
3 Q |
- |
- |
- |
16.04 % |
| Evelo Biosciences Inc |
3 Q |
- |
- |
- |
- |
| Eyenovia Inc |
3 Q |
- |
- |
- |
- |
| Fate Therapeutics inc |
3 Q |
- |
- |
- |
- |
| Fennec Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Homology Medicines Inc |
2 Q |
- |
- |
- |
- |
| Fulgent Genetics Inc |
3 Q |
74.18 % |
45.85 % |
49.75 % |
43.55 % |
| Forma Therapeutics Holdings Inc |
2 Q |
- |
- |
- |
- |
| Foamix Pharmaceuticals Ltd |
4 Q |
- |
- |
- |
181.74 % |
| Frequency Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Global Future City Holding Inc. |
1 Q |
64.93 % |
- |
- |
- |
| Fusion Pharmaceuticals Inc |
2 Q |
- |
- |
- |
- |
| Genetic Technologies Ltd |
2 Q |
- |
- |
- |
- |
| Gentium S.p.a. |
0 Q |
- |
- |
- |
- |
| Synageva Biopharma Corp |
0 Q |
- |
- |
- |
- |
| Gilead Sciences Inc |
3 Q |
82.65 % |
5.37 % |
93.36 % |
6.14 % |
| Glucose Health, Inc. |
3 Q |
96.68 % |
78.92 % |
- |
- |
| Genocea Biosciences Inc |
3 Q |
- |
- |
- |
- |
| Aevi Genomic Medicine, Inc. |
3 Q |
- |
- |
- |
- |
| Gossamer Bio Inc |
3 Q |
- |
- |
- |
- |
| Green Planet Bio Engineering Co Ltd |
3 Q |
- |
- |
- |
- |
| Optec International, Inc. |
1 Q |
- |
- |
- |
- |
| Gritstone Oncology Inc |
3 Q |
- |
- |
- |
- |
| Galera Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Guided Therapeutics Inc |
3 Q |
84.42 % |
- |
- |
- |
| Genethera Inc |
3 Q |
- |
- |
- |
- |
| G1 Therapeutics Inc |
3 Q |
- |
- |
15.32 % |
- |
| Gtx Corp |
3 Q |
48.84 % |
0.86 % |
- |
- |
| Halozyme Therapeutics Inc |
2 Q |
89.61 % |
46.75 % |
52.13 % |
- |
| Hubei Minkang Pharmaceutical Ltd. |
0 Q |
- |
- |
- |
- |
| Health Discovery Corp |
3 Q |
- |
- |
- |
- |
| Aim Immunotech Inc |
3 Q |
- |
- |
- |
- |
| Inhibitor Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Hyperion Therapeutics Inc |
0 Q |
- |
- |
- |
- |
| Heska Corp |
1 Q |
43.87 % |
- |
- |
- |
| Hst Global Inc |
3 Q |
- |
- |
- |
- |
| Idera Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Igm Biosciences Inc |
3 Q |
- |
- |
- |
- |
| Intelgenx Technologies Corp |
3 Q |
- |
- |
27.06 % |
- |
| Intellect Neurosciences, Inc. |
4 Q |
- |
- |
- |
- |
| Immuron Ltd |
2 Q |
72.65 % |
- |
- |
- |
| Conversion Labs Inc |
3 Q |
75.15 % |
- |
5.27 % |
- |
| Epicure Charcoal, Inc. |
4 Q |
- |
- |
- |
- |
| Immunomedics Inc |
2 Q |
91.69 % |
- |
- |
- |
| Immune Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Immunovant Inc |
3 Q |
- |
- |
- |
- |
| Integrated Biopharma Inc |
3 Q |
15.64 % |
6.86 % |
- |
94.28 % |
| Infinity Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Artemis Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Innovus Pharmaceuticals, Inc. |
3 Q |
61.51 % |
- |
- |
- |
| Iovance Biotherapeutics inc |
2 Q |
- |
- |
- |
- |
| Iteos Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Iterum Therapeutics Plc |
3 Q |
- |
- |
- |
- |
| Renovacare Inc |
3 Q |
- |
- |
- |
- |
| Jounce Therapeutics Inc |
1 Q |
- |
- |
- |
74.73 % |
| Juno Therapeutics, Inc. |
4 Q |
- |
- |
- |
- |
| Cadus Corp |
1 Q |
- |
- |
- |
- |
| Kite Pharma, Inc. |
2 Q |
- |
- |
- |
- |
| Krystal Biotech Inc |
3 Q |
- |
- |
- |
- |
| Kitov Pharma Ltd |
4 Q |
- |
- |
- |
54.27 % |
| Kazia Therapeutics Ltd |
2 Q |
- |
- |
- |
- |
| Lescarden Inc |
0 Q |
- |
- |
- |
- |
| Lineage Cell Therapeutics Inc |
3 Q |
82.14 % |
- |
- |
- |
| Atyr Pharma Inc |
3 Q |
- |
- |
- |
- |
| Lixte Biotechnology Holdings Inc |
3 Q |
- |
- |
- |
- |
| La Jolla Pharmaceutical Company |
3 Q |
72.56 % |
- |
- |
- |
| Lazuriton Nano Biotechnology u s a Inc |
3 Q |
- |
- |
- |
- |
| Apollo Endosurgery, Inc. |
1 Q |
58.38 % |
- |
- |
- |
| Livongo Health Inc |
2 Q |
76.65 % |
- |
- |
1.36 % |
| Luckwel Pharmaceuticals Inc. |
2 Q |
- |
- |
- |
- |
| Mateon Therapeutics Inc |
1 Q |
- |
- |
- |
- |
| Mabvax Therapeutics Holdings, Inc. |
3 Q |
80.38 % |
8.52 % |
5.63 % |
- |
| Multicell Technologies, Inc. |
4 Q |
- |
- |
- |
- |
| Cannabis Global Inc |
3 Q |
- |
- |
- |
- |
| Madrigal Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Manhattan Pharmaceuticals Inc |
0 Q |
- |
- |
- |
- |
| Micromet, Inc. |
0 Q |
- |
- |
- |
- |
| Mj Pharmaceuticals Inc. |
0 Q |
- |
- |
- |
- |
| Cure Pharmaceutical Holding Corp |
3 Q |
24.48 % |
- |
- |
31.23 % |
| Momenta Pharmaceuticals inc |
2 Q |
- |
- |
- |
- |
| Banner Energy Services Corp |
2 Q |
- |
- |
- |
- |
| Medicure Inc |
4 Q |
63.95 % |
- |
- |
- |
| Merus N v |
3 Q |
- |
- |
- |
- |
| Midatech Pharma Plc |
4 Q |
- |
- |
- |
- |
| Myriad Genetics Inc |
3 Q |
72.52 % |
- |
- |
- |
| Mymetics Corp |
3 Q |
- |
- |
- |
- |
| Myokardia Inc |
3 Q |
- |
- |
- |
- |
| Myrexis, Inc. |
0 Q |
- |
- |
- |
- |
| Navidea Biopharmaceuticals Inc |
3 Q |
99.97 % |
- |
- |
- |
| Nascent Biotech Inc |
3 Q |
- |
- |
- |
- |
| Neurocrine Biosciences Inc |
3 Q |
98.96 % |
- |
3.95 % |
12.57 % |
| Northsight Capital, Inc. |
2 Q |
- |
- |
12.19 % |
- |
| Neogen Corp |
3 Q |
46.01 % |
14.51 % |
- |
8.43 % |
| Nexus Biopharma Inc |
0 Q |
- |
- |
- |
- |
| Nightstar Therapeutics Plc |
1 Q |
- |
- |
- |
- |
| Nantkwest Inc |
3 Q |
- |
- |
- |
- |
| Neoleukin Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Biovie Inc |
3 Q |
- |
- |
- |
- |
| Nutra Pharma Corp. |
1 Q |
81.96 % |
- |
5.96 % |
- |
| Nanostring Technologies Inc |
3 Q |
56.16 % |
- |
9.14 % |
- |
| Intellia Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Nbty Inc |
4 Q |
46.59 % |
6.51 % |
- |
- |
| Nugene International, Inc. |
0 Q |
- |
- |
- |
- |
| Nutrastar International Inc. |
0 Q |
- |
- |
- |
- |
| Novavax Inc |
3 Q |
- |
- |
- |
- |
| N-viro International Corporation |
0 Q |
- |
- |
- |
- |
| Nexien Biopharma Inc |
3 Q |
- |
- |
- |
- |
| Nymox Pharmaceutical Corporation |
4 Q |
50 % |
- |
- |
- |
| Obalon Therapeutics Inc |
3 Q |
6.82 % |
- |
- |
- |
| Oncbiomune Pharmaceuticals Inc |
1 Q |
- |
- |
- |
- |
| Ocugen Inc |
3 Q |
- |
- |
- |
- |
| Oncocyte Corp |
3 Q |
- |
- |
- |
- |
| Spark Therapeutics Inc |
2 Q |
90.39 % |
- |
- |
- |
| Oncternal Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Outlook Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Organovo Holdings Inc |
3 Q |
- |
- |
- |
- |
| Orgenesis Inc |
3 Q |
- |
- |
- |
- |
| Osiris Therapeutics, Inc. |
1 Q |
72.01 % |
- |
- |
8.17 % |
| Oncovista Innovative Therapies, Inc |
0 Q |
- |
- |
- |
- |
| Oxford Immunotec Global Plc |
3 Q |
76.45 % |
- |
- |
- |
| Mateon Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Gt Biopharma Inc |
3 Q |
- |
- |
- |
- |
| Oyster Point Pharma Inc |
3 Q |
- |
- |
- |
- |
| Prolor Biotech, Inc. |
0 Q |
- |
- |
- |
- |
| Vaxcyte Inc |
2 Q |
- |
- |
- |
- |
| Procyon Corp |
3 Q |
73.17 % |
17.58 % |
0.63 % |
11.13 % |
| Pdl Biopharma Inc |
3 Q |
40.67 % |
- |
- |
- |
| Quint Media Inc. |
0 Q |
- |
- |
- |
- |
| Petvivo Holdings Inc |
2 Q |
- |
- |
- |
- |
| Phathom Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Protokinetix Inc |
3 Q |
- |
- |
- |
- |
| Pulse biosciences inc |
3 Q |
- |
- |
- |
- |
| Protalix Biotherapeutics inc |
3 Q |
73.42 % |
- |
80.54 % |
- |
| Pharmacyte Biotech Inc |
2 Q |
- |
- |
- |
- |
| Predictive Oncology Inc |
3 Q |
63.56 % |
- |
- |
- |
| Prana Biotechnology Ltd |
2 Q |
- |
- |
- |
- |
| Precipio Inc |
3 Q |
23.17 % |
- |
- |
- |
| Pluristem Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Poseida Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Proteo Inc |
1 Q |
- |
- |
- |
- |
| Portage Biotech Inc |
1 Q |
- |
- |
- |
- |
| Protagonist Therapeutics inc |
3 Q |
- |
- |
- |
- |
| Proteostasis Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Pulmatrix Inc |
3 Q |
- |
- |
- |
- |
| Pivot Pharmaceuticals Inc. |
1 Q |
- |
- |
- |
- |
| Q Biomed Inc |
3 Q |
- |
- |
- |
- |
| Quidel Corporation |
3 Q |
80.58 % |
48.79 % |
1.04 % |
56.48 % |
| Qiagen N v |
4 Q |
65.86 % |
- |
- |
- |
| Quest Patent Research Corp |
3 Q |
- |
1.46 % |
- |
- |
| Qrons Inc |
3 Q |
- |
- |
- |
- |
| Quotient Limited |
2 Q |
39.33 % |
- |
38.17 % |
- |
| Quanterix Corp |
2 Q |
39.7 % |
- |
- |
- |
| Quint Media Inc. |
0 Q |
- |
- |
- |
- |
| Rapt Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Rich Pharmaceuticals, Inc. |
4 Q |
- |
- |
- |
- |
| Regenocell Therapeutics, Inc. |
0 Q |
- |
- |
- |
- |
| Receptos, Inc. |
0 Q |
- |
- |
- |
- |
| Arcus Biosciences Inc |
3 Q |
- |
2.82 % |
- |
- |
| Ridgefield Acquisition Corp |
3 Q |
- |
- |
- |
- |
| Replicel Life Sciences Inc. |
4 Q |
- |
- |
- |
- |
| Restorgenex Corp |
0 Q |
- |
- |
- |
- |
| Reynolds Consumer Products Inc |
2 Q |
30.66 % |
13.63 % |
23.36 % |
- |
| Regen Biopharma Inc |
2 Q |
- |
- |
- |
- |
| Regado Biosciences Inc |
0 Q |
- |
- |
- |
- |
| Repligen Corp |
3 Q |
57.87 % |
15.47 % |
- |
4.03 % |
| Regenxbio Inc |
3 Q |
82.45 % |
8.89 % |
- |
- |
| Regenerx Biopharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Riot Blockchain Inc |
3 Q |
47.12 % |
- |
- |
- |
| Relay Therapeutics Inc |
2 Q |
- |
- |
- |
- |
| Relmada Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Royalty Pharma Plc |
2 Q |
90.75 % |
- |
- |
25.22 % |
| Respirerx Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Aytu Bioscience, Inc. |
0 Q |
- |
- |
- |
- |
| Ruthigen, Inc. |
0 Q |
- |
- |
- |
- |
| Rubius Therapeutics inc |
2 Q |
- |
- |
- |
- |
| Revolution Medicines Inc |
2 Q |
- |
- |
- |
- |
| Radient Pharmaceuticals Corp |
0 Q |
- |
- |
- |
- |
| Strongbridge Biopharma plc |
3 Q |
94.94 % |
- |
- |
- |
| Scpharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Sangui Biotech International Inc |
3 Q |
- |
- |
29.39 % |
- |
| Seagen Inc |
3 Q |
92.63 % |
59.92 % |
75.55 % |
24.5 % |
| Sangamo Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Shengtai Pharmaceutical, Inc. |
0 Q |
- |
- |
- |
- |
| Skinovation Pharmaceutical Inc |
3 Q |
- |
- |
- |
- |
| Skinvisible Inc |
3 Q |
- |
- |
- |
- |
| Solid Biosciences Inc |
3 Q |
- |
- |
- |
- |
| Salarius Pharmaceuticals inc |
3 Q |
- |
- |
- |
- |
| Sun Biopharma Inc |
3 Q |
- |
- |
- |
- |
| Seneca Biopharma Inc |
3 Q |
- |
- |
- |
- |
| Syndax Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Soligenix Inc |
3 Q |
36.49 % |
- |
28.66 % |
- |
| Sienna Biopharmaceuticals, Inc. |
3 Q |
- |
- |
- |
- |
| Senesco Technologies Inc |
0 Q |
- |
- |
- |
- |
| Senesco Technologies Inc |
4 Q |
- |
- |
- |
- |
| Spero Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Surgalign Holdings Inc |
3 Q |
57.42 % |
- |
- |
- |
| Scholar Rock Holding Corp |
2 Q |
- |
- |
- |
- |
| Neuronetics Inc |
3 Q |
78.66 % |
- |
- |
- |
| Spotlight Innovation Inc. |
1 Q |
80.25 % |
- |
- |
- |
| Satsuma Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Surface Oncology Inc |
3 Q |
- |
- |
- |
- |
| Sunwin Stevia International Inc |
2 Q |
2.37 % |
- |
- |
- |
| Intellicell Biosciences, Inc. |
0 Q |
- |
- |
- |
- |
| Savient Pharmaceuticals Inc |
0 Q |
- |
- |
- |
- |
| Springworks Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Protara Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Tobira Therapeutics, Inc. |
0 Q |
- |
- |
- |
- |
| Tracon Pharmaceuticals Inc |
3 Q |
- |
- |
- |
- |
| Bio techne Corp |
3 Q |
67.45 % |
16.35 % |
11.16 % |
18.27 % |
| Telik Inc |
0 Q |
- |
- |
- |
- |
| Mabvax Therapeutics Holdings, Inc. |
0 Q |
- |
- |
- |
- |
| Tongli Pharmaceuticals (usa), Inc. |
4 Q |
- |
- |
- |
- |
| Tg Therapeutics inc |
3 Q |
- |
- |
- |
- |
| Tg Therapeutics, Inc. |
0 Q |
- |
- |
- |
- |
| Twinlab Consolidated Holdings Inc |
3 Q |
20.15 % |
- |
2.28 % |
- |
| Mitesco Inc |
3 Q |
- |
- |
- |
- |
| Targeted Medical Pharma, Inc. |
0 Q |
- |
- |
- |
- |
| Targacept Inc |
0 Q |
- |
- |
- |
- |
| Therapix Biosciences Ltd. |
2 Q |
- |
- |
- |
- |
| Therapeutic Solutions International Inc |
3 Q |
76 % |
- |
- |
- |
| Trius Therapeutics Inc |
0 Q |
- |
- |
- |
- |
| Taxus Pharmaceuticals Holdings, Inc. |
1 Q |
- |
- |
- |
- |
| Unity Biotechnology Inc |
3 Q |
- |
- |
- |
- |
| Uluru Inc. |
1 Q |
68.55 % |
- |
- |
- |
| United Bancshares Inc |
0 Q |
- |
- |
- |
- |
| Urogen Pharma Ltd |
3 Q |
91.07 % |
- |
- |
- |
| Urovant Sciences Ltd |
3 Q |
- |
- |
- |
- |
| Avricore Health Inc. |
4 Q |
- |
- |
- |
- |
| Vitality Biopharma Inc |
3 Q |
- |
- |
- |
- |
| Vericel Corporation |
3 Q |
69.66 % |
11.22 % |
- |
0.13 % |
| Vir Biotechnology Inc |
3 Q |
- |
- |
- |
- |
| Meridian Bioscience Inc |
3 Q |
60.02 % |
10.12 % |
- |
20.93 % |
| Volitionrx Ltd |
3 Q |
- |
- |
- |
- |
| Viropharma Inc |
0 Q |
- |
- |
- |
- |
| Vistagen Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Ventrus Biosciences Inc |
0 Q |
- |
- |
- |
- |
| Vaxart Inc |
3 Q |
- |
- |
- |
- |
| Voyager Therapeutics Inc |
3 Q |
- |
72.65 % |
2.65 % |
37.97 % |
| Warner Chilcott Plc |
0 Q |
- |
- |
- |
- |
| Windtree Therapeutics Inc |
3 Q |
- |
- |
- |
- |
| Weikang Bio-technology Group Co., Inc. |
0 Q |
- |
- |
- |
- |
| Wave Life Sciences Ltd |
3 Q |
- |
- |
- |
- |
| Xenetic Biosciences Inc |
3 Q |
- |
- |
- |
- |
| Acceleron Pharma inc |
3 Q |
- |
- |
- |
- |
| Xstelos Holdings, Inc. |
0 Q |
- |
- |
- |
- |
| Vilacto Bio Inc. |
2 Q |
18 % |
- |
- |
- |
| Zai Lab Limited |
4 Q |
71.13 % |
- |
- |
- |
| Zymeworks Inc |
3 Q |
- |
- |
- |
- |
Tweet
